Topic
del-desiran
Amgen Falls 10 Percent After Novartis Cholesterol Trial Failure
Amgen shares fell 10% after a series of clinical trial failures at Novartis triggered a class-wide re-evaluation of experimental cardiovascular drugs.
Oil nears 100 dollars a barrel as Middle East attacks disrupt supply
Brent crude surged to $99.2 a barrel amid Middle East supply disruptions, while Novartis shares plummeted following a disappointing late-stage drug trial.